intervention in elderly patients with hip fractures who are in receipt of anticoagulation. Although the study was retrospective and the sample size was small, the groups being compared were well defined. However, the complications encountered needed further elucidation. Poh and Lingaraj 6 followed up 294 patients who underwent hip fracture surgery to evaluate various postoperative complications and risk factors. The study method was in line with evidence-based medicine, but the duration of followup was not reported. Al Khudairy et al. 7 reported that withholding clopidogrel for <7 days before hip fracture surgery had no discernible effect on patients, although the sample size was small.
Few would debate the need to balance between maximal antithrombotic efficacy and minimal bleeding in choosing a thromboprophylactic strategy, but there is less agreement as to how best to accomplish this task. The American Academy of Orthopaedic Surgeons and the American College of Chest Physicians have published their own guidelines, which entail subtle differences. 8 This further illustrates the difficulty in evaluating the best evidence available. Practising surgeons should study these guidelines, evaluate the evidence, and come up with the best solutions for their own patients.
